Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
L HermleE Gouzoulis

Abstract

The so-called entactogens 3,4-methylenedioxymethamphetamine ([MDMA] also known as "Ecstasy," or "Adam") and its analog 3,4-methylenedioxyethamphetamine ([MDE] also known as "Eve") exert similar psychotropic effects in humans. Two double-blind placebo-controlled psychometric studies with normal control subjects were conducted. Placebo or MDE (140 mg) was administered orally to eight male volunteers at 1:30 P.M. and to six subjects (3 male, 3 female) at 11 P.M. Psychologic tests and clinical ratings were performed 1 hour before the administration of the drugs, as well as 2, 5, and 24 hours after drug intake and 7 days thereafter in the first study. In the second study, measures were taken at times -1, +8.5, +24 hours, and +7 days. The majority of the psychotropic effects resembled those that have already been described in anecdotal reports. The substance produced a partially controllable state of enhanced insight, empathy, and peaceful feelings. All subjects displayed a general stimulation with increased psychomotor drive, logorrhea, and facilitation of communication. One of the fourteen volunteers developed a toxic psychosis. One volunteer displayed a dysphoric reaction, one suffered from episodes of anxiety for some days after ...Continue Reading

Citations

Oct 24, 2009·Der Nervenarzt·C NormannM Berger
Mar 12, 1999·Neuroscience and Biobehavioral Reviews·K M HegadorenM Bourin
Apr 2, 2003·Pharmacology & Therapeutics·J C Cole, H R Sumnall
May 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·E D O'LoinsighK M O'Boyle
Oct 27, 1997·Forensic Science International : Synergy·M RotheJ Kunkel
Jul 22, 1998·Forensic Science International : Synergy·T KellerH Tsuchihashi
Apr 15, 2003·Journal of Psychoactive Drugs·Franz X VollenweiderMark Geyer
Nov 14, 2008·Journal of Psychoactive Drugs·José Carlos BousoGregorio Gómez-Jarabo
Dec 7, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Stephen J TraubLewis S Nelson
Sep 18, 2008·Pediatric Emergency Care·Raymond Farah, Rola Farah
Oct 6, 2007·Expert Opinion on Drug Metabolism & Toxicology·Graham R Jang, Robert Z Harris
Jan 16, 2009·Journal of Chromatography. a·Zeineb AturkiFranco Tagliaro
Jul 25, 2013·Human Psychopharmacology·Máté Kapitány-FövényZsolt Demetrovics
Apr 11, 2012·Pharmacology, Biochemistry, and Behavior·Adam L HalberstadtMark A Geyer
Jun 29, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E Maldonado, J F Navarro
Jul 19, 2008·Journal of Psychopharmacology·F HaslerF X Vollenweider
Jan 13, 2006·Journal of Psychopharmacology·Harry R SumnallLisa Jerome
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·Cándido Hernández-LópezRafael de La Torre
Jun 5, 2004·CNS Drug Reviews·Roland W Freudenmann, Manfred Spitzer
Aug 30, 2019·AACN Advanced Critical Care·Ruff Joseph Macale Cajanding
Oct 10, 2021·Neuroscience and Biobehavioral Reviews·Andrea J NarayanAmie C Hayley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.